VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q4 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,084,333 | -11.5% | 40,295 | -0.9% | 0.05% | -8.5% |
| Q2 2023 | $1,224,634 | -8.1% | 40,672 | -1.2% | 0.06% | -28.0% |
| Q1 2023 | $1,332,270 | +26.4% | 41,183 | +12.0% | 0.08% | +9.3% |
| Q4 2022 | $1,054,211 | +16.2% | 36,783 | -2.2% | 0.08% | 0.0% |
| Q3 2022 | $907,000 | -15.9% | 37,608 | -4.4% | 0.08% | -16.7% |
| Q2 2022 | $1,078,000 | -54.1% | 39,356 | -35.7% | 0.09% | -46.1% |
| Q1 2022 | $2,348,000 | +256.8% | 61,225 | +199.0% | 0.17% | +240.8% |
| Q4 2021 | $658,000 | +8.9% | 20,476 | -0.2% | 0.05% | -41.0% |
| Q3 2021 | $604,000 | – | 20,508 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |